Korro Bio Inc (KRRO)
50.13
-4.88
(-8.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.37
-0.76
(-1.52%)
After-Hours: 20:00
Korro Bio Total Assets (Quarterly): 249.59M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 249.59M |
| March 31, 2024 | 197.98M |
| September 30, 2023 | 95.83M |
| Date | Value |
|---|---|
| June 30, 2023 | 109.34M |
| December 31, 2022 | 73.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
73.74M
Minimum
Dec 2022
249.59M
Maximum
Jun 2024
145.30M
Average
109.34M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics Inc | 11.68M |
| Pliant Therapeutics Inc | 445.66M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.51M |
| Shareholders Equity (Quarterly) | 198.08M |